Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
VCYT

Market Cap: $3.26B

VI

Veracyte, Inc.

VCYT

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin72.09%

EBITDA Margin23.10%

EBIT Margin19.39%

Pre-tax Margin19.39%

Net Profit Margin20.37%

Earnings Yield3.52%

Valuation Multiples

Price / Book2.34

Price / Sales5.80

Price / Earnings28.38

PEG0.09

Forward PEG13.28

EV / Sales5.34

EV / EBITDA23.13

EV / Operating Cash Flow16.83

EV / Free Cash Flow18.14

Price / Free Cash Flow19.71

Price / Operating Cash Flow18.25

Cash Flow & Capital

Free Cash Flow / Share$2.08

Operating Cash Flow / Share$2.24

Free Cash Flow Yield5.07%

Capex / Revenue2.30%

Capex / Operating Cash Flow7.25%

Capex / Depreciation0.62

Stock Compensation / Revenue8.63%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio9.16

Quick Ratio8.80

Cash Ratio4.77

Debt / Assets0.03

Debt / Capital0.03

Debt / Equity0.03

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-2.00

Solvency Ratio1.38

Financial Leverage1.07

Efficiency & Working Capital

Asset Turnover0.38

Fixed Asset Turnover9.84

Inventory Turnover6.92

Receivables Turnover10.37

Payables Turnover19.54

Days Sales Outstanding35.19

Days Inventory Outstanding52.74

Days Payables Outstanding18.68

Operating Cycle87.93

Cash Conversion Cycle69.25

Working Capital Turnover1.15

Returns & Quality

Return on Equity8.64%

Return on Assets7.70%

Return on Invested Capital6.70%

ROCE6.72%

Return on Tangible Assets17.99%

Operating Return on Assets6.55%

Income Quality1.56

Tax Burden1.05

Interest Burden1.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$3B

Invested Capital$1.42B

Working Capital$512.04M

Tangible Asset Value$538.55M

Net Current Asset Value$476.81M

Graham Number$23.74

Graham Net-Net$5.51

Book Value / Share$17.43

Tangible Book Value / Share$6.76

Cash / Share$6.09

Financial Health Scores

Piotroski Score7

Altman Z-Score21.27

Revenue$561.9M

EBIT$108.94M

Market Cap$3.35B

Working Capital$512.04M

Retained Earnings$-323.43M

Total Assets$1.49B

Total Liabilities$97.96M